Show simple item record

dc.contributor.authorAspergillosis Subcommittee of the Health Protection Surveillance Centre Scientific Advisory Committee
dc.date.accessioned2018-01-31T16:51:55Z
dc.date.available2018-01-31T16:51:55Z
dc.date.issued2018-01
dc.identifier.isbn978-0-9565622-6-5
dc.identifier.urihttp://hdl.handle.net/10147/622761
dc.descriptionNosocomial aspergillosis is now well described and a better understanding of the disease and preventive strategies has resulted in a reduction in the incidence and mortality in certain high-risk populations, such as prolonged neutropenia, and haematopoietic stem cell transplantation, where appropriate preventive measures have been taken (1, 2). However, recent data have also identified changes in the epidemiology of aspergillosis with the recognition of a much broader group of at-risk patients including those with chronic obstructive pulmonary disease (COPD), burns, chronic granulomatous disorder (CGD), cystic fibrosis, neonates, and also some patients not typically regarded as immunocompromised (3). In terms of risk exposures, the association with certain types of construction activity is well recognised and the need for preventive measures whilst such activities are taking place has been accepted. However, other risk exposures for nosocomial aspergillosis may also be important and healthcare providers must ensure that all recognised risks are minimised.en
dc.language.isoenen
dc.publisherHealth Protection Surveillance Centreen
dc.subjectaspergillosisen
dc.subjectLUNG DISEASEen
dc.titleNational Guidelines for the Prevention of Nosocomial Aspergillosisen
dc.typeReporten
refterms.dateFOA2018-08-28T01:15:30Z


Files in this item

Thumbnail
Name:
Aspergillus Guidelines 2018.pdf
Size:
627.8Kb
Format:
PDF
Description:
Guidelines

This item appears in the following Collection(s)

Show simple item record